Largest Drug Manufacturers - General Companies by Market Cap
The Drug Manufacturers - General sector has 85 publicly listed stocks with a combined market cap of $6.86 Trillion. Eli Lilly and Company leads the sector with a market cap of $866.32 Billion. This ranking covers all Drug Manufacturers - General stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$6.86 Trillion
Companies Listed
85
Largest Company
Eli Lilly and …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Eli Lilly and Company
NYSE:LLY |
$866.32 Billion | $866.32 Billion | USA | $967.93 | +0.48% | +9.50% | 74.20 Million |
| 2 |
Eli Lilly and Company
SA:LILY34 |
$853.51 Billion | R$4.35 Trillion | Brazil | R$153.70 | +0.70% | -0.16% | 250.45K |
| 3 |
Johnson & Johnson
NYSE:JNJ |
$540.16 Billion | $540.16 Billion | USA | $224.20 | -1.32% | -1.45% | 167.51 Million |
| 4 |
AbbVie Inc
NYSE:ABBV |
$368.06 Billion | $368.06 Billion | USA | $208.16 | +0.76% | +4.76% | 141.79 Million |
| 5 |
AstraZeneca PLC
MX:AZNN |
$290.50 Billion | MX$5.05 Trillion | Mexico | MX$1628.00 | +1.25% | -4.81% | 6.50K |
| 6 |
AstraZeneca PLC
NASDAQ:AZN |
$284.42 Billion | $284.42 Billion | USA | $183.46 | -0.69% | -3.31% | 45.42 Million |
| 7 |
Novartis AG ADR
NYSE:NVS |
$281.41 Billion | $281.41 Billion | USA | $147.48 | +0.11% | -3.02% | 34.68 Million |
| 8 |
Merck & Company Inc
NYSE:MRK |
$280.74 Billion | $280.74 Billion | USA | $113.11 | +0.85% | +1.08% | 224.68 Million |
| 9 |
Roche Holding AG
SW:ROG |
$279.33 Billion | CHF220.94 Billion | Switzerland | CHF320.70 | +0.79% | -8.76% | 28.40 Million |
| 10 |
Novartis AG
MX:NVSN |
$278.95 Billion | MX$4.85 Trillion | Mexico | MX$2540.22 | -2.22% | -5.36% | 13.80K |
| 11 |
Roche Holding AG
SW:ROP |
$254.60 Billion | CHF201.38 Billion | Switzerland | CHF316.50 | -0.60% | -2.59% | 21.97 Million |
| 12 |
AstraZeneca PLC
F:ZEGA |
$252.57 Billion | €216.04 Billion | Germany | €75.50 | -3.82% | -2.58% | 3.45K |
| 13 |
Novartis AG
SW:NOVN |
$241.30 Billion | CHF190.86 Billion | Switzerland | CHF113.84 | -1.78% | -2.10% | 58.01 Million |
| 14 |
Amgen Inc
NASDAQ:AMGN |
$174.56 Billion | $174.56 Billion | USA | $323.85 | -1.81% | -6.01% | 61.74 Million |
| 15 |
Gilead Sciences Inc
NASDAQ:GILD |
$164.63 Billion | $164.63 Billion | USA | $132.69 | +0.79% | +1.76% | 127.84 Million |
| 16 |
Pfizer Inc
NYSE:PFE |
$149.53 Billion | $149.53 Billion | USA | $26.30 | -0.11% | -2.59% | 751.19 Million |
| 17 |
Novo Nordisk A/S
CO:NOVO-B |
$149.27 Billion | Dkr954.06 Billion | Denmark | Dkr282.95 | +1.78% | +8.85% | 138.51 Million |
| 18 |
Pfizer Inc
SA:PFIZ34 |
$147.67 Billion | R$752.56 Billion | Brazil | R$33.09 | -0.78% | -2.25% | 179.03K |
| 19 |
Bristol-Myers Squibb Company
NYSE:BMY |
$116.81 Billion | $116.81 Billion | USA | $57.38 | -1.44% | -2.27% | 222.20 Million |
| 20 |
Sanofi
MX:SNYN |
$111.20 Billion | MX$1.93 Trillion | Mexico | MX$800.08 | -5.32% | -6.53% | 7.46K |
| 21 |
GlaxoSmithKline PLC ADR
NYSE:GSK |
$111.15 Billion | $111.15 Billion | USA | $55.63 | -0.13% | -3.77% | 93.36 Million |
| 22 |
GlaxoSmithKline plc
MX:GSKN |
$109.41 Billion | MX$1.90 Trillion | Mexico | MX$947.40 | +0.00% | -5.26% | 993.00 |
| 23 |
Sanofi
F:SNW2 |
$105.72 Billion | €90.43 Billion | Germany | €37.80 | -4.06% | -8.25% | 381.00 |
| 24 |
GSK PLC SP. ADR/2 NEW
F:GS70 |
$101.34 Billion | €86.68 Billion | Germany | €47.20 | +0.00% | -3.28% | 120.00 |
| 25 |
Sanofi SA
PA:SAN |
$95.70 Billion | €81.86 Billion | France | €77.81 | -2.52% | -4.83% | 56.87 Million |
| 26 |
Roche Holding AG
SW:RO |
$43.81 Billion | CHF34.65 Billion | Switzerland | CHF324.80 | -0.55% | -2.70% | 726.79K |
| 27 |
Bayer AG NA
XETRA:BAYN |
$42.96 Billion | €36.74 Billion | Germany | €37.40 | -1.71% | -6.59% | 59.80 Million |
| 28 |
Biogen Inc
NASDAQ:BIIB |
$27.47 Billion | $27.47 Billion | USA | $187.21 | +0.08% | +1.53% | 31.36 Million |
| 29 |
ASTELLAS PHARMA UNSP.ADR
F:YPHA |
$19.55 Billion | €16.72 Billion | Germany | €12.90 | +0.00% | -3.73% | 2.40K |
| 30 |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
$12.67 Billion | CN¥86.61 Billion | China | CN¥143.55 | +3.04% | +1.15% | 53.27 Million |
| 31 |
CSPC PHARMACEUT.GR. ADR4
F:CVGU |
$11.04 Billion | €9.44 Billion | Germany | €3.52 | +0.00% | -6.38% | 45.00 |
| 32 |
CSPC Pharmaceutical Group Limited
F:CVG |
$10.18 Billion | €8.71 Billion | Germany | €0.91 | +1.93% | -3.60% | 1.83K |
| 33 |
Orion Oyj B
HE:ORNBV |
$8.48 Billion | €7.25 Billion | Finland | €69.15 | +0.66% | -0.50% | 4.07 Million |
| 34 |
ORION CORP.B UNSP.ADR 1/2
F:OFK0 |
$8.31 Billion | €7.10 Billion | Germany | €36.20 | -1.09% | -0.55% | 40.00 |
| 35 |
Sichuan Kelun Pharmaceutical Co Ltd
SHE:002422 |
$8.08 Billion | CN¥55.24 Billion | China | CN¥34.57 | +1.38% | +2.10% | 495.57 Million |
| 36 |
Grifols S.A.
MC:GRF |
$4.50 Billion | €3.85 Billion | Spain | €9.11 | +1.63% | +1.74% | 61.27 Million |
| 37 |
GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO |
$4.31 Billion | Rs398.09 Billion | India | Rs2349.90 | +0.58% | -5.80% | 1.69 Million |
| 38 |
GRIFOLS ADR 1/2/EO-50
F:G0F |
$4.21 Billion | €3.60 Billion | Germany | €4.26 | -2.74% | -1.84% | 192.00 |
| 39 |
Virbac SA
PA:VIRP |
$3.01 Billion | €2.58 Billion | France | €362.50 | -2.42% | -4.23% | 90.46K |
| 40 |
Orion Oyj A
HE:ORNAV |
$2.57 Billion | €2.20 Billion | Finland | €69.00 | +1.32% | -0.72% | 232.10K |
| 41 |
AstraZeneca PLC
LSE:AZN |
$2.55 Billion | GBX20.95 Trillion | UK | GBX13512.00 | -3.13% | -6.76% | 49.60 Million |
| 42 |
Pfizer Limited
NSE:PFIZER |
$2.31 Billion | Rs214.05 Billion | India | Rs4679.00 | -0.67% | -2.18% | 387.83K |
| 43 |
Kalbe Farma Tbk PT
JK:KLBF |
$2.30 Billion | Rp39.20 Trillion | Indonesia | Rp865.00 | +0.00% | -4.95% | 1.11 Billion |
| 44 |
Aurora Optoelectronics Co Ltd
SHG:600666 |
$2.11 Billion | CN¥14.42 Billion | China | CN¥5.24 | -5.59% | -23.17% | 13.06 Billion |
| 45 |
Organon & Co
NYSE:OGN |
$2.11 Billion | $2.11 Billion | USA | $13.26 | -0.23% | +17.76% | 385.51 Million |
| 46 |
Grifols S.A
F:G0FB |
$2.08 Billion | €1.78 Billion | Germany | €6.90 | +4.55% | -1.43% | 324.00 |
| 47 |
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
$1.99 Billion | CN¥13.60 Billion | China | CN¥11.18 | -0.53% | -6.99% | 478.88 Million |
| 48 |
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357 |
$1.95 Billion | CN¥13.30 Billion | China | CN¥25.40 | -1.82% | -4.65% | 276.73 Million |
| 49 |
Cosmo Pharmaceuticals N.V
F:C43 |
$1.65 Billion | €1.42 Billion | Germany | €87.90 | -0.79% | -12.97% | 1.28K |
| 50 |
Zhejiang Jolly Pharmaceutical Co Ltd
SHE:300181 |
$1.56 Billion | CN¥10.67 Billion | China | CN¥15.21 | -1.36% | -4.46% | 279.44 Million |
| 51 |
COSMO Pharmaceuticals SA
SW:COPN |
$1.52 Billion | CHF1.20 Billion | Switzerland | CHF80.30 | -2.07% | -15.30% | 1.33 Million |
| 52 |
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
$1.20 Billion | CN¥8.20 Billion | China | CN¥16.76 | -0.83% | -6.79% | 168.71 Million |
| 53 |
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR |
$1.18 Billion | Rs109.12 Billion | India | Rs4738.00 | -0.54% | +3.23% | 340.28K |
| 54 |
NanJing Pharmaceutical Co Ltd
SHG:600713 |
$1.01 Billion | CN¥6.91 Billion | China | CN¥5.28 | -2.94% | -7.37% | 1.25 Billion |
| 55 |
Chongqing Lummy Pharmaceutical
SHE:300006 |
$987.34 Million | CN¥6.75 Billion | China | CN¥6.39 | -0.78% | -0.16% | 1.70 Billion |
| 56 |
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096 |
$936.00 Million | CN¥6.40 Billion | China | CN¥58.56 | +4.66% | +1.54% | 68.51 Million |
| 57 |
GlaxoSmithKline PLC
LSE:GSK |
$929.05 Million | GBX7.64 Trillion | UK | GBX1901.00 | -1.43% | -8.43% | 134.50 Million |
| 58 |
Hunan Jingfeng Pharmaceutical
SHE:000908 |
$916.62 Million | CN¥6.26 Billion | China | CN¥7.12 | -3.39% | +0.85% | 575.27 Million |
| 59 |
Sanofi India Limited
NSE:SANOFI |
$846.80 Million | Rs78.30 Billion | India | Rs3399.90 | -0.21% | -1.32% | 1.06 Million |
| 60 |
Zhejiang Int'L Group Co Ltd
SHE:000411 |
$809.52 Million | CN¥5.53 Billion | China | CN¥10.60 | -0.19% | -2.03% | 114.28 Million |
| 61 |
Hangzhou Minsheng Healthcare Co Ltd
SHE:301507 |
$770.10 Million | CN¥5.26 Billion | China | CN¥14.76 | +0.75% | +3.22% | 87.57 Million |
| 62 |
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281 |
$597.24 Million | CN¥4.08 Billion | China | CN¥37.69 | -0.53% | -4.24% | 108.97 Million |
| 63 |
SENORES PHARMACEUTICALS L
NSE:SENORES |
$445.38 Million | Rs41.18 Billion | India | Rs894.25 | -0.55% | -0.74% | 7.08 Million |
| 64 |
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
$433.71 Million | CN¥2.96 Billion | China | CN¥5.84 | +0.00% | -23.46% | 465.45 Million |
| 65 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
SHG:600613 |
$412.42 Million | CN¥2.82 Billion | China | CN¥5.88 | +0.17% | +0.51% | 503.26 Million |
| 66 |
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
$404.75 Million | R$2.06 Billion | Brazil | R$13.82 | +1.84% | +1.02% | 18.96 Million |
| 67 |
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
$403.85 Million | CN¥2.76 Billion | China | CN¥8.26 | +0.24% | -4.18% | 186.87 Million |
| 68 |
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
$374.97 Million | CN¥2.56 Billion | China | CN¥7.39 | +1.65% | +10.79% | 239.38 Million |
| 69 |
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671 |
$354.80 Million | CN¥2.42 Billion | China | CN¥19.91 | +1.37% | +4.73% | 63.53 Million |
| 70 |
Amarin Corporation PLC
NASDAQ:AMRN |
$296.25 Million | $296.25 Million | USA | $14.24 | +1.21% | -0.49% | 1.82 Million |
| 71 |
Chorokbaem Healthcare Co Ltd
KO:118000 |
$242.13 Million | ₩357.29 Billion | Korea | ₩2080.00 | +0.00% | +766.67% | 26.22 Million |
| 72 |
NGL Fine-Chem Limited
NSE:NGLFINE |
$150.94 Million | Rs13.96 Billion | India | Rs2259.10 | +2.01% | -1.18% | 165.15K |
| 73 |
TTK Healthcare Limited
NSE:TTKHLTCARE |
$141.93 Million | Rs13.12 Billion | India | Rs928.75 | +2.73% | -0.20% | 175.08K |
| 74 |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KQ:307750 |
$131.08 Million | ₩193.43 Billion | Korea | ₩3855.00 | -1.41% | -0.26% | 16.43 Million |
| 75 |
PharmGen Science Inc
KO:004720 |
$61.63 Million | ₩90.94 Billion | Korea | ₩4150.00 | -1.07% | +7.93% | 2.29 Million |
| 76 |
Scilex Holding Company
NASDAQ:SCLX |
$58.44 Million | $58.44 Million | USA | $11.15 | +5.39% | +66.67% | 1.60 Million |
| 77 |
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA |
$43.13 Million | $43.13 Million | USA | $1.03 | -0.96% | -1.90% | 3.75 Million |
| 78 |
Singbao International Co Ltd
TWO:6130 |
$33.78 Million | NT$1.07 Billion | Taiwan | NT$24.20 | -0.82% | -8.33% | 7.54 Million |
| 79 |
BCWORLD PHARM. Co. Ltd
KQ:200780 |
$30.55 Million | ₩45.09 Billion | Korea | ₩4410.00 | -0.79% | -2.86% | 425.24K |
| 80 |
Korean Drug Co. Ltd
KQ:014570 |
$30.25 Million | ₩44.63 Billion | Korea | ₩4125.00 | -1.55% | +0.12% | 507.43K |
| 81 |
Nasus Pharma Ltd.
NYSE MKT:NSRX |
$27.17 Million | $27.17 Million | USA | $2.70 | -1.82% | -25.00% | 2.55 Million |
| 82 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904 |
$26.01 Million | $26.01 Million | China | $0.48 | +0.00% | -2.46% | 2.89 Million |
| 83 |
Yung Zip Chemical Ind Co Ltd
TWO:4102 |
$24.03 Million | NT$762.73 Million | Taiwan | NT$18.00 | -1.37% | -4.76% | 1.25 Million |
| 84 |
Lipidor Ab
ST:LIPI |
$18.82 Million | Skr174.88 Million | Sweden | Skr0.22 | +0.00% | +0.00% | 219.74 Million |
| 85 |
Firebrick Pharma Ltd
AU:FRE |
$9.47 Million | AU$13.38 Million | Australia | AU$0.05 | +0.00% | -1.85% | 3.60 Million |
Track real-time market capitalization of largest public companies in the Drug Manufacturers - General industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - general corporations. View all industries